• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX15 HOLLOW FIBER OXYGENATOR AF; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX15 HOLLOW FIBER OXYGENATOR AF; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number 1CX*FX15E
Device Problem Obstruction of Flow (2423)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/19/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Udi - not yet required for this product code/lot number combination, however the di portion was provided.The actual device has not been returned to the manufacturing facility.However, a photograph of the involved device was returned for evaluation.Therefore, the investigation was based upon evaluation of user facility information, a photograph of the involved device and a retention sample of the involved product code/lot# combination.The returned photograph of the actual device revealed the adhesion of clots inside the oxygenator module and on the rib set inside the venous filter.Visual inspection of the retention sample revealed no defects.The retention sample was built into a circuit with tubes and bovine blood was circulated through it.The pressure drop was determined at each specified flow rate.The obtained values were verified to meet manufacturing specification.No obstruction was observed inside the oxygenator module.Bovine blood was then circulated for 6 hours and no obstruction was observed inside the oxygenator module.The bovine blood was rinsed out of the retention sample and was subjected to another visual inspection.No obstruction was observed inside the oxygenator module.The actual device has not been returned to the manufacturing facility for evaluation and the investigation is still on going.For this reason, (b)(4).A follow up report will be submitted within 30 days of this report being sent.A review of the device history record and product release decision control sheet of the involved product/lot# combinations was conducted with no relevant findings.A search of the complaint file found no report with the presumed product code/lot# combinations.(b)(4).All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported the oxygenator flow suddenly started dropping to where the customer could not get adequate flow.Follow up communication with the user facility confirmed the following information: the customer went on pump today and flow was fine; all blood gasses were fine and suddenly flow started dropping and the customer could not get adequate flow; flow dropped down to 2 lpm however all blood gas levels remained the same and in good parameters; the customer changed out the fx15r in 2-3 minutes with no major delay and the patient never lost oxygenation; svo2 got down to 66 but once changed out and back on the pump everything worked well as usual; the surgery was completed successfully; and there was no impact to the patient.
 
Manufacturer Narrative
This report is being submitted to provide the device return date in device available for evaluation? & to provide the returned sample evaluation results.The actual device was returned to the manufacturing facility for evaluation.Visual inspection revealed that some clots had been formed inside the oxygenator module.The actual sample was rinsed and dried and then subjected to another visual inspection and revealed no defects.The actual sample was built into a circuit with tubes.Bovine blood was circulated in the circuit and the pressure drop was determined at each flow rate.The obtained values were confirmed to meet manufacturer specifications and no obstruction that could lead to an increase in the pressure was found.Bovine blood was circulated in the circuit for 6 hours.No obstruction was observed that could lead to an increase in the pressure.The actual sample was then rinsed out.Subsequent visual inspection confirmed no clot formation.There is no evidence that this event was related to a device defect or malfunction and the exact cause of the reported event cannot be definitively determined based on the investigation results.All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX15 HOLLOW FIBER OXYGENATOR AF
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
jennifer suh
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key6108930
MDR Text Key60093590
Report Number9681834-2016-00254
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350701183
UDI-Public04987350701183
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/17/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2019
Device Catalogue Number1CX*FX15E
Device Lot Number160609
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/29/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received11/29/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/09/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-